Salami E, Rotimi O
Toxicol Rep. 2024; 13:101773.
PMID: 39526236
PMC: 11550589.
DOI: 10.1016/j.toxrep.2024.101773.
Liu L, Liu S, Bai F, Deng Y, Zhang X, Wang L
J Inflamm Res. 2024; 17:4701-4719.
PMID: 39051051
PMC: 11268657.
DOI: 10.2147/JIR.S460437.
Xie N, Wang F, Chen D, Zhou J, Xu J, Qu F
PLoS One. 2024; 19(3):e0300461.
PMID: 38512862
PMC: 10956758.
DOI: 10.1371/journal.pone.0300461.
Peerwani G, Rozi S, Lakhdir M, Zuberi N, Asad N
Front Glob Womens Health. 2023; 4:967883.
PMID: 37415597
PMC: 10321523.
DOI: 10.3389/fgwh.2023.967883.
Zhou J, Zuo W, Tan Y, Wang X, Zhu M, Zhang H
J Ovarian Res. 2023; 16(1):54.
PMID: 36932420
PMC: 10022207.
DOI: 10.1186/s13048-023-01130-4.
Association of FSHR and DENND1A polymorphisms with polycystic ovary syndrome: a meta-analysis.
Larsen C, Kudela E, Biringer K
JBRA Assist Reprod. 2022; 27(1):60-70.
PMID: 36350975
PMC: 10065767.
DOI: 10.5935/1518-0557.20220043.
Relationship between the follicular distribution pattern of polycystic ovaries and the degree of menstrual disturbance and serum sex steroid levels.
Mills G, Goorah B, Elizur S, Son W, Dahan M
Turk J Obstet Gynecol. 2022; 19(3):215-220.
PMID: 36149262
PMC: 9511927.
DOI: 10.4274/tjod.galenos.2022.63255.
Reconsidering the Polycystic Ovary Syndrome (PCOS).
Gleicher N, Darmon S, Patrizio P, Barad D
Biomedicines. 2022; 10(7).
PMID: 35884809
PMC: 9313207.
DOI: 10.3390/biomedicines10071505.
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome.
McDonnell T, Cussen L, McIlroy M, OReilly M
Ther Adv Endocrinol Metab. 2022; 13:20420188221113140.
PMID: 35874313
PMC: 9297442.
DOI: 10.1177/20420188221113140.
The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.
Bruni V, Capozzi A, Lello S
Reprod Sci. 2021; 29(3):668-679.
PMID: 33709373
DOI: 10.1007/s43032-021-00515-4.
PCOSKB: a database of genes, diseases, pathways, and networks associated with polycystic ovary syndrome.
Sharma M, Barai R, Kundu I, Bhaye S, Pokar K, Idicula-Thomas S
Sci Rep. 2020; 10(1):14738.
PMID: 32895427
PMC: 7477240.
DOI: 10.1038/s41598-020-71418-8.
Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India.
Ganie M, Vasudevan V, Wani I, Baba M, Arif T, Rashid A
Indian J Med Res. 2019; 150(4):333-344.
PMID: 31823915
PMC: 6902362.
DOI: 10.4103/ijmr.IJMR_1937_17.
Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women.
Pradas I, Rovira-Llopis S, Naudi A, Banuls C, Rocha M, Hernandez-Mijares A
Sci Rep. 2019; 9(1):16033.
PMID: 31690730
PMC: 6831788.
DOI: 10.1038/s41598-019-52263-w.
Correlation between Clinical Features, Biochemical Parameters, and Histopathological Findings in Women with Patterned Baldness: A Study from North India.
Tandon S, Arora P, Gautam R, Bhardwaj M, Garga U, Sharma N
J Cutan Aesthet Surg. 2019; 12(1):42-48.
PMID: 31057268
PMC: 6484563.
DOI: 10.4103/JCAS.JCAS_30_18.
Birthweight and PCOS: systematic review and meta-analysis.
Sadrzadeh S, Hui E, Schoonmade L, Painter R, Lambalk C
Hum Reprod Open. 2019; 2017(2):hox010.
PMID: 30895228
PMC: 6276673.
DOI: 10.1093/hropen/hox010.
The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy.
Spinedi E, Cardinali D
Int J Endocrinol. 2018; 2018:1349868.
PMID: 30147722
PMC: 6083563.
DOI: 10.1155/2018/1349868.
Effectiveness of Laser Acupoints on Women With Polycystic Ovarian Syndrome: A Randomized Controlled Trial.
El-Shamy F, El-Kholy S, El-Rahman M
J Lasers Med Sci. 2018; 9(2):113-120.
PMID: 30026896
PMC: 6046386.
DOI: 10.15171/jlms.2018.22.
Polycystic Ovary Syndrome and Periodontal disease: Underlying Links- A Review.
Tanguturi S, Nagarakanti S
Indian J Endocrinol Metab. 2018; 22(2):267-273.
PMID: 29911043
PMC: 5972486.
DOI: 10.4103/ijem.IJEM_577_17.
Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome.
Jove M, Pradas I, Naudi A, Rovira-Llopis S, Banuls C, Rocha M
Oncotarget. 2018; 9(4):4522-4536.
PMID: 29435121
PMC: 5796992.
DOI: 10.18632/oncotarget.23393.
Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy.
Yao K, Bian C, Zhao X
Exp Ther Med. 2017; 14(2):1271-1276.
PMID: 28810587
PMC: 5526116.
DOI: 10.3892/etm.2017.4642.